Compare MGYR & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGYR | SEER |
|---|---|---|
| Founded | 1922 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.1M | 97.3M |
| IPO Year | 2021 | 2020 |
| Metric | MGYR | SEER |
|---|---|---|
| Price | $17.40 | $1.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.2K | ★ 534.1K |
| Earning Date | 04-23-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | ★ 26.83 | 9.40 |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | $35.34 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $15.22 | $1.65 |
| 52 Week High | $20.00 | $2.41 |
| Indicator | MGYR | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 45.35 |
| Support Level | $17.04 | $1.71 |
| Resistance Level | $17.99 | $1.84 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 26.47 | 6.44 |
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.